289 related articles for article (PubMed ID: 7091432)
21. Haloperidol plasma level after a test dose as predictor for the clinical response to treatment in acute schizophrenic patients.
Louza Neto MR; Müller-Spahn F; Rüther E; Scherer J
Pharmacopsychiatry; 1988 Sep; 21(5):226-31. PubMed ID: 3227054
[TBL] [Abstract][Full Text] [Related]
22. Plasma clozapine and haloperidol concentrations in adolescents with childhood-onset schizophrenia: association with response.
Piscitelli SC; Frazier JA; McKenna K; Albus KE; Grothe DR; Gordon CT; Rapoport JL
J Clin Psychiatry; 1994 Sep; 55 Suppl B():94-7. PubMed ID: 7961584
[TBL] [Abstract][Full Text] [Related]
23. Negative correlation between alpha-1-acid-glycoprotein plasma level and response to haloperidol in the acute treatment of schizophrenia.
Levinson I; Levine S
Biol Psychiatry; 1995 Aug; 38(3):198-200. PubMed ID: 7578667
[No Abstract] [Full Text] [Related]
24. Clinical response and plasma haloperidol levels in chronic and subchronic schizophrenia.
Santos JL; Cabranes JA; Vazquez C; Fuentenebro F; Almoguera I; Ramos JA
Biol Psychiatry; 1989 Aug; 26(4):381-8. PubMed ID: 2669981
[TBL] [Abstract][Full Text] [Related]
25. Effective clinical response at low plasma levels of haloperidol in Japanese schizophrenics with acute psychotic state.
Jibiki I; Kubota T; Fujimoto K; Sakamoto H; Hasegawa M; Furuta H; Yamaguchi N
Jpn J Psychiatry Neurol; 1993 Sep; 47(3):627-9. PubMed ID: 8301878
[No Abstract] [Full Text] [Related]
26. A two-phase, double-blind randomized study of three haloperidol plasma levels for acute psychosis with reassignment of initial non-responders.
Janicak PG; Javaid JI; Sharma RP; Leach A; Dowd S; Davis JM
Acta Psychiatr Scand; 1997 Apr; 95(4):343-50. PubMed ID: 9150830
[TBL] [Abstract][Full Text] [Related]
27. Determination of plasma haloperidol concentrations by radioreceptor assay in schizophrenia: clinical utility.
Santos JL; Ramos JA; Prieto P; Almoguera I; Vazquez C; Rubio ME; Cabranes JA
Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(6):917-25. PubMed ID: 2813809
[TBL] [Abstract][Full Text] [Related]
28. Plasma haloperidol levels: clinical response and fancy mathematics.
Van Putten T; Marder SR; Mintz J
Arch Gen Psychiatry; 1985 Aug; 42(8):835-8. PubMed ID: 4015328
[No Abstract] [Full Text] [Related]
29. Further evidence of a dose-response threshold for haloperidol in psychosis.
Stone CK; Garve DL; Griffith J; Hirschowitz J; Bennett J
Am J Psychiatry; 1995 Aug; 152(8):1210-2. PubMed ID: 7625474
[TBL] [Abstract][Full Text] [Related]
30. Effects of repeated drug holidays on serum haloperidol concentrations, psychiatric symptoms, and movement disorders in schizophrenic patients.
Newton JE; Cannon DJ; Couch L; Fody EP; McMillan DE; Metzer WS; Paige SR; Reid GM; Summers BN
J Clin Psychiatry; 1989 Apr; 50(4):132-5. PubMed ID: 2925601
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and side effects of haloperidol in psychotic patients: oral versus intravenous administration.
Möller HJ; Kissling W; Lang C; Doerr P; Pirke KM; von Zerssen D
Am J Psychiatry; 1982 Dec; 139(12):1571-5. PubMed ID: 7149056
[TBL] [Abstract][Full Text] [Related]
32. The relationship of haloperidol concentrations to therapeutic response.
Perry PJ; Pfohl BM; Kelly MW
J Clin Psychopharmacol; 1988 Feb; 8(1):38-43. PubMed ID: 3350997
[TBL] [Abstract][Full Text] [Related]
33. Serum haloperidol concentrations and clinical response in acute psychosis.
Miller DD; Hershey LA; Duffy JP; Abernethy DR; Greenblatt DJ
J Clin Psychopharmacol; 1984 Dec; 4(6):305-10. PubMed ID: 6511996
[TBL] [Abstract][Full Text] [Related]
34. Plasma catecholamine metabolites and early response to haloperidol.
Bowers MB; Swigar ME; Jatlow PI; Goicoechea N
J Clin Psychiatry; 1984 Jun; 45(6):248-51. PubMed ID: 6725216
[TBL] [Abstract][Full Text] [Related]
35. Serum haloperidol concentration and clinical response in schizophrenia.
Kirch DG; Bigelow LB; Korpi ER; Wagner RL; Zalcman S; Wyatt RJ
Schizophr Bull; 1988; 14(2):283-9. PubMed ID: 3201181
[TBL] [Abstract][Full Text] [Related]
36. The Dose Reduction in Schizophrenia (DORIS) Study: a final report.
Hirschowitz J; Hitzemann R; Piscani K; Burr G; Frecska E; Culliton D; Mann M; Curtis C
Schizophr Res; 1997 Jan; 23(1):31-43. PubMed ID: 9050126
[TBL] [Abstract][Full Text] [Related]
37. Plasma haloperidol levels and clinical response: confounding variables.
Mavroidis ML; Garver DL; Kanter DR; Hirschowitz J
Psychopharmacol Bull; 1985; 21(1):62-5. PubMed ID: 3983340
[No Abstract] [Full Text] [Related]
38. The interpretation of plasma haloperidol concentrations.
Kirch DG; Bigelow LB; Wyatt RJ
Arch Gen Psychiatry; 1985 Aug; 42(8):838-40. PubMed ID: 4015329
[No Abstract] [Full Text] [Related]
39. Plasma and red cell levels of thioridazine and clinical response in schizophrenia.
Smith RC; Baumgartner R; Ravichandran GK; Shvartsburd A; Schoolar JC; Allen P; Johnson R
Psychiatry Res; 1984 Aug; 12(4):287-96. PubMed ID: 6594712
[TBL] [Abstract][Full Text] [Related]
40. Lowest effective dose of depot neuroleptics.
Hoencamp E; Haffmans PJ; Jansen GS
Br J Psychiatry; 1992 Mar; 160():422-3. PubMed ID: 1348655
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
